14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Genocea Biosciences Stock and on which exchange is it traded?
The symbol for Genocea Biosciences is GNCA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Genocea Biosciences Stock?
Genocea Biosciences holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Genocea Biosciences Stock?
Genocea Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Genocea Biosciences Stock.

What's the current price of Genocea Biosciences Stock?
As of the end of day on the Apr 19, 2023, the price of an Genocea Biosciences (GNCA) share was $0.0001.

What is the 52-week high and low for Genocea Biosciences Stock?
The 52-week high for Genocea Biosciences Stock is $0.469 and the 52-week low is $0.0001.
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT